ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
Interest to research in the development of new formulations of antituberculosis drugs due to the high incidence of tuberculosis in the Republic of Kazakhstan and the Russian Federation nowadays, including with acquired drug resistance. The reason for the development of acquired drug resistance is to...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2016-09-01
|
| シリーズ: | Фармация и фармакология (Пятигорск) |
| 主題: | |
| オンライン･アクセス: | https://www.pharmpharm.ru/jour/article/view/203 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|